Endolytix

Beverly, United States

Endolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections.

Aug 2024

Debt Financing

Top Investors

Morningside

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Endolytix's investors?

Endolytix's investors include Morningside.

Where is Endolytix headquartered?

Endolytix is headquartered in Beverly, United States.

What does Endolytix do?

Endolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections.

What stage is Endolytix at?

Endolytix is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 7, 2024.

MLA

"Endolytix — Funding & Investors." VCBacked, August 7, 2024, https://www.vcbacked.co/company/endolytix. Accessed July 1, 2026.

APA

VCBacked. (2024). Endolytix — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/endolytix

Wikipedia (cite web)

{{cite web |title=Endolytix — Funding & Investors |url=https://www.vcbacked.co/company/endolytix |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 7, 2024.